nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—ABCB1—esophageal cancer	0.264	1	CbGaD
Amitriptyline—HRH2—gastric juice—esophageal cancer	0.0363	0.248	CbGeAlD
Amitriptyline—CYP2C9—Capecitabine—esophageal cancer	0.0152	0.258	CbGbCtD
Amitriptyline—CYP2B6—Cisplatin—esophageal cancer	0.0145	0.246	CbGbCtD
Amitriptyline—HTR7—vagus nerve—esophageal cancer	0.00991	0.0676	CbGeAlD
Amitriptyline—NTRK2—neck—esophageal cancer	0.00953	0.065	CbGeAlD
Amitriptyline—ALB—Methotrexate—esophageal cancer	0.00923	0.157	CbGbCtD
Amitriptyline—CYP2C9—Cisplatin—esophageal cancer	0.00766	0.13	CbGbCtD
Amitriptyline—ABCB1—Cisplatin—esophageal cancer	0.00743	0.126	CbGbCtD
Amitriptyline—HTR2A—vagus nerve—esophageal cancer	0.00618	0.0422	CbGeAlD
Amitriptyline—ABCB1—Methotrexate—esophageal cancer	0.00483	0.082	CbGbCtD
Amitriptyline—Paresthesia of limbs—Methotrexate—esophageal cancer	0.0046	0.0428	CcSEcCtD
Amitriptyline—NTRK2—lung—esophageal cancer	0.00412	0.0281	CbGeAlD
Amitriptyline—CHRM3—exocrine gland—esophageal cancer	0.00357	0.0244	CbGeAlD
Amitriptyline—KCNQ3—lung—esophageal cancer	0.00312	0.0213	CbGeAlD
Amitriptyline—NTRK2—lymph node—esophageal cancer	0.00282	0.0192	CbGeAlD
Amitriptyline—CHRM5—epithelium—esophageal cancer	0.00278	0.019	CbGeAlD
Amitriptyline—Inappropriate antidiuretic hormone secretion—Cisplatin—esophageal cancer	0.00277	0.0257	CcSEcCtD
Amitriptyline—Ileus paralytic—Capecitabine—esophageal cancer	0.00274	0.0255	CcSEcCtD
Amitriptyline—ADRA1D—epithelium—esophageal cancer	0.00248	0.017	CbGeAlD
Amitriptyline—KCND3—lung—esophageal cancer	0.00237	0.0162	CbGeAlD
Amitriptyline—Cardiomyopathy—Capecitabine—esophageal cancer	0.00232	0.0215	CcSEcCtD
Amitriptyline—HRH2—digestive system—esophageal cancer	0.00221	0.0151	CbGeAlD
Amitriptyline—HTR7—neck—esophageal cancer	0.00217	0.0148	CbGeAlD
Amitriptyline—Ageusia—Cisplatin—esophageal cancer	0.00198	0.0185	CcSEcCtD
Amitriptyline—HRH2—lung—esophageal cancer	0.00185	0.0126	CbGeAlD
Amitriptyline—Bone marrow depression—Capecitabine—esophageal cancer	0.00175	0.0163	CcSEcCtD
Amitriptyline—SIGMAR1—bronchus—esophageal cancer	0.00171	0.0116	CbGeAlD
Amitriptyline—Dysarthria—Cisplatin—esophageal cancer	0.0017	0.0158	CcSEcCtD
Amitriptyline—Torsade de pointes—Capecitabine—esophageal cancer	0.00169	0.0157	CcSEcCtD
Amitriptyline—SIGMAR1—smooth muscle tissue—esophageal cancer	0.00167	0.0114	CbGeAlD
Amitriptyline—KCND3—lymph node—esophageal cancer	0.00162	0.0111	CbGeAlD
Amitriptyline—Ventricular fibrillation—Capecitabine—esophageal cancer	0.00155	0.0144	CcSEcCtD
Amitriptyline—Body temperature increased—Carboplatin—esophageal cancer	0.00155	0.0144	CcSEcCtD
Amitriptyline—CHRM1—trachea—esophageal cancer	0.00154	0.0105	CbGeAlD
Amitriptyline—SIGMAR1—trachea—esophageal cancer	0.00153	0.0104	CbGeAlD
Amitriptyline—CHRM3—smooth muscle tissue—esophageal cancer	0.0015	0.0102	CbGeAlD
Amitriptyline—HTR7—epithelium—esophageal cancer	0.00148	0.0101	CbGeAlD
Amitriptyline—Tingling sensation—Capecitabine—esophageal cancer	0.00147	0.0137	CcSEcCtD
Amitriptyline—Ageusia—Capecitabine—esophageal cancer	0.00146	0.0136	CcSEcCtD
Amitriptyline—ADRA1A—epithelium—esophageal cancer	0.00143	0.00974	CbGeAlD
Amitriptyline—HTR7—smooth muscle tissue—esophageal cancer	0.00143	0.00973	CbGeAlD
Amitriptyline—HTR2A—neck—esophageal cancer	0.00136	0.00925	CbGeAlD
Amitriptyline—SLC6A4—digestive system—esophageal cancer	0.00133	0.00905	CbGeAlD
Amitriptyline—HTR7—trachea—esophageal cancer	0.00131	0.00893	CbGeAlD
Amitriptyline—Bone marrow depression—Methotrexate—esophageal cancer	0.00131	0.0122	CcSEcCtD
Amitriptyline—ORM1—lung—esophageal cancer	0.0013	0.00887	CbGeAlD
Amitriptyline—HRH2—lymph node—esophageal cancer	0.00126	0.00863	CbGeAlD
Amitriptyline—Dysarthria—Capecitabine—esophageal cancer	0.00125	0.0117	CcSEcCtD
Amitriptyline—Coordination abnormal—Capecitabine—esophageal cancer	0.00121	0.0112	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Cisplatin—esophageal cancer	0.00119	0.0111	CcSEcCtD
Amitriptyline—CHRM3—digestive system—esophageal cancer	0.00118	0.00807	CbGeAlD
Amitriptyline—HTR7—digestive system—esophageal cancer	0.00113	0.00768	CbGeAlD
Amitriptyline—CYP2B6—bronchus—esophageal cancer	0.00111	0.0076	CbGeAlD
Amitriptyline—Irritability—Cisplatin—esophageal cancer	0.00111	0.0104	CcSEcCtD
Amitriptyline—SLC6A4—lung—esophageal cancer	0.00111	0.00756	CbGeAlD
Amitriptyline—HRH1—epithelium—esophageal cancer	0.0011	0.00754	CbGeAlD
Amitriptyline—CHRM1—lung—esophageal cancer	0.0011	0.00753	CbGeAlD
Amitriptyline—SIGMAR1—lung—esophageal cancer	0.0011	0.00751	CbGeAlD
Amitriptyline—CYP2C19—digestive system—esophageal cancer	0.0011	0.0075	CbGeAlD
Amitriptyline—ADRA2A—bronchus—esophageal cancer	0.00107	0.00729	CbGeAlD
Amitriptyline—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00107	0.00992	CcSEcCtD
Amitriptyline—HRH1—smooth muscle tissue—esophageal cancer	0.00106	0.00726	CbGeAlD
Amitriptyline—Mental disability—Capecitabine—esophageal cancer	0.00103	0.00957	CcSEcCtD
Amitriptyline—Sleep disorder—Capecitabine—esophageal cancer	0.000993	0.00925	CcSEcCtD
Amitriptyline—Sweating increased—Cisplatin—esophageal cancer	0.000982	0.00914	CcSEcCtD
Amitriptyline—HRH1—trachea—esophageal cancer	0.000977	0.00666	CbGeAlD
Amitriptyline—SLC6A2—lung—esophageal cancer	0.000975	0.00665	CbGeAlD
Amitriptyline—Vascular purpura—Capecitabine—esophageal cancer	0.000961	0.00895	CcSEcCtD
Amitriptyline—ADRA2A—trachea—esophageal cancer	0.000959	0.00655	CbGeAlD
Amitriptyline—Pancytopenia—Cisplatin—esophageal cancer	0.000958	0.00891	CcSEcCtD
Amitriptyline—Hepatic failure—Capecitabine—esophageal cancer	0.000957	0.00891	CcSEcCtD
Amitriptyline—HTR7—lung—esophageal cancer	0.00094	0.00641	CbGeAlD
Amitriptyline—Dysarthria—Methotrexate—esophageal cancer	0.000932	0.00868	CcSEcCtD
Amitriptyline—Libido decreased—Capecitabine—esophageal cancer	0.000927	0.00863	CcSEcCtD
Amitriptyline—HTR2A—epithelium—esophageal cancer	0.000922	0.00629	CbGeAlD
Amitriptyline—CYP1A2—digestive system—esophageal cancer	0.000898	0.00613	CbGeAlD
Amitriptyline—Purpura—Capecitabine—esophageal cancer	0.000892	0.0083	CcSEcCtD
Amitriptyline—ORM1—lymph node—esophageal cancer	0.000889	0.00607	CbGeAlD
Amitriptyline—HTR2A—smooth muscle tissue—esophageal cancer	0.000889	0.00607	CbGeAlD
Amitriptyline—DRD2—lung—esophageal cancer	0.000889	0.00606	CbGeAlD
Amitriptyline—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000886	0.00825	CcSEcCtD
Amitriptyline—Arthritis—Capecitabine—esophageal cancer	0.000885	0.00824	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000881	0.0082	CcSEcCtD
Amitriptyline—Myocardial infarction—Cisplatin—esophageal cancer	0.000881	0.0082	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000878	0.00817	CcSEcCtD
Amitriptyline—Stomatitis—Cisplatin—esophageal cancer	0.000876	0.00816	CcSEcCtD
Amitriptyline—CYP3A5—digestive system—esophageal cancer	0.000866	0.00591	CbGeAlD
Amitriptyline—CYP2B6—digestive system—esophageal cancer	0.00086	0.00587	CbGeAlD
Amitriptyline—Osteoarthritis—Capecitabine—esophageal cancer	0.00086	0.008	CcSEcCtD
Amitriptyline—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000853	0.00794	CcSEcCtD
Amitriptyline—CYP2C9—digestive system—esophageal cancer	0.000852	0.00581	CbGeAlD
Amitriptyline—HRH1—digestive system—esophageal cancer	0.00084	0.00573	CbGeAlD
Amitriptyline—Irritability—Capecitabine—esophageal cancer	0.000821	0.00764	CcSEcCtD
Amitriptyline—Urinary retention—Capecitabine—esophageal cancer	0.000818	0.00761	CcSEcCtD
Amitriptyline—HTR2A—trachea—esophageal cancer	0.000816	0.00557	CbGeAlD
Amitriptyline—Ataxia—Capecitabine—esophageal cancer	0.000809	0.00753	CcSEcCtD
Amitriptyline—CYP2E1—digestive system—esophageal cancer	0.000807	0.00551	CbGeAlD
Amitriptyline—Coma—Methotrexate—esophageal cancer	0.000806	0.0075	CcSEcCtD
Amitriptyline—Gynaecomastia—Methotrexate—esophageal cancer	0.000789	0.00734	CcSEcCtD
Amitriptyline—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000785	0.00731	CcSEcCtD
Amitriptyline—ALB—lymph node—esophageal cancer	0.00078	0.00532	CbGeAlD
Amitriptyline—Tinnitus—Cisplatin—esophageal cancer	0.000752	0.007	CcSEcCtD
Amitriptyline—SIGMAR1—lymph node—esophageal cancer	0.000752	0.00513	CbGeAlD
Amitriptyline—CYP1A2—lung—esophageal cancer	0.00075	0.00512	CbGeAlD
Amitriptyline—Sweating increased—Capecitabine—esophageal cancer	0.000724	0.00674	CcSEcCtD
Amitriptyline—CYP3A5—lung—esophageal cancer	0.000723	0.00493	CbGeAlD
Amitriptyline—Arrhythmia—Cisplatin—esophageal cancer	0.000721	0.00671	CcSEcCtD
Amitriptyline—CYP2B6—lung—esophageal cancer	0.000719	0.0049	CbGeAlD
Amitriptyline—Alopecia—Cisplatin—esophageal cancer	0.000713	0.00664	CcSEcCtD
Amitriptyline—Hepatic failure—Methotrexate—esophageal cancer	0.000712	0.00663	CcSEcCtD
Amitriptyline—Pancytopenia—Capecitabine—esophageal cancer	0.000706	0.00657	CcSEcCtD
Amitriptyline—HTR2A—digestive system—esophageal cancer	0.000702	0.00479	CbGeAlD
Amitriptyline—HRH1—lung—esophageal cancer	0.000702	0.00479	CbGeAlD
Amitriptyline—ADRA2A—lung—esophageal cancer	0.000689	0.0047	CbGeAlD
Amitriptyline—Weight increased—Capecitabine—esophageal cancer	0.000676	0.0063	CcSEcCtD
Amitriptyline—CYP2E1—lung—esophageal cancer	0.000674	0.0046	CbGeAlD
Amitriptyline—SLC6A2—lymph node—esophageal cancer	0.000667	0.00455	CbGeAlD
Amitriptyline—Vision blurred—Cisplatin—esophageal cancer	0.000662	0.00616	CcSEcCtD
Amitriptyline—Tremor—Cisplatin—esophageal cancer	0.000658	0.00613	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000653	0.00608	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000653	0.00608	CcSEcCtD
Amitriptyline—Ill-defined disorder—Cisplatin—esophageal cancer	0.000652	0.00607	CcSEcCtD
Amitriptyline—CYP3A4—digestive system—esophageal cancer	0.00065	0.00443	CbGeAlD
Amitriptyline—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00065	0.00605	CcSEcCtD
Amitriptyline—Myocardial infarction—Capecitabine—esophageal cancer	0.00065	0.00605	CcSEcCtD
Amitriptyline—Jaundice—Capecitabine—esophageal cancer	0.000646	0.00601	CcSEcCtD
Amitriptyline—Stomatitis—Capecitabine—esophageal cancer	0.000646	0.00601	CcSEcCtD
Amitriptyline—Osteoarthritis—Methotrexate—esophageal cancer	0.00064	0.00596	CcSEcCtD
Amitriptyline—CYP2D6—digestive system—esophageal cancer	0.000639	0.00436	CbGeAlD
Amitriptyline—Malaise—Cisplatin—esophageal cancer	0.000634	0.0059	CcSEcCtD
Amitriptyline—Leukopenia—Cisplatin—esophageal cancer	0.000629	0.00585	CcSEcCtD
Amitriptyline—Agranulocytosis—Capecitabine—esophageal cancer	0.000618	0.00576	CcSEcCtD
Amitriptyline—Irritability—Methotrexate—esophageal cancer	0.000611	0.00569	CcSEcCtD
Amitriptyline—Convulsion—Cisplatin—esophageal cancer	0.000609	0.00567	CcSEcCtD
Amitriptyline—ABCB1—epithelium—esophageal cancer	0.000604	0.00413	CbGeAlD
Amitriptyline—Ataxia—Methotrexate—esophageal cancer	0.000602	0.0056	CcSEcCtD
Amitriptyline—Anxiety—Cisplatin—esophageal cancer	0.000596	0.00555	CcSEcCtD
Amitriptyline—Hepatitis—Capecitabine—esophageal cancer	0.000595	0.00554	CcSEcCtD
Amitriptyline—Hypoaesthesia—Capecitabine—esophageal cancer	0.000592	0.00551	CcSEcCtD
Amitriptyline—Discomfort—Cisplatin—esophageal cancer	0.000591	0.0055	CcSEcCtD
Amitriptyline—HTR2A—lung—esophageal cancer	0.000586	0.004	CbGeAlD
Amitriptyline—Oedema—Cisplatin—esophageal cancer	0.000573	0.00534	CcSEcCtD
Amitriptyline—Thrombocytopenia—Cisplatin—esophageal cancer	0.000561	0.00522	CcSEcCtD
Amitriptyline—Tachycardia—Cisplatin—esophageal cancer	0.00056	0.00521	CcSEcCtD
Amitriptyline—Tinnitus—Capecitabine—esophageal cancer	0.000555	0.00516	CcSEcCtD
Amitriptyline—Hyperhidrosis—Cisplatin—esophageal cancer	0.000554	0.00516	CcSEcCtD
Amitriptyline—Eosinophilia—Methotrexate—esophageal cancer	0.000548	0.0051	CcSEcCtD
Amitriptyline—Anorexia—Cisplatin—esophageal cancer	0.000547	0.00509	CcSEcCtD
Amitriptyline—Hypotension—Cisplatin—esophageal cancer	0.000536	0.00499	CcSEcCtD
Amitriptyline—ABCB1—trachea—esophageal cancer	0.000535	0.00365	CbGeAlD
Amitriptyline—Arrhythmia—Capecitabine—esophageal cancer	0.000531	0.00495	CcSEcCtD
Amitriptyline—Alopecia—Capecitabine—esophageal cancer	0.000526	0.00489	CcSEcCtD
Amitriptyline—Pancytopenia—Methotrexate—esophageal cancer	0.000525	0.00489	CcSEcCtD
Amitriptyline—Paraesthesia—Cisplatin—esophageal cancer	0.000515	0.00479	CcSEcCtD
Amitriptyline—Erectile dysfunction—Methotrexate—esophageal cancer	0.00051	0.00474	CcSEcCtD
Amitriptyline—Dysgeusia—Capecitabine—esophageal cancer	0.000507	0.00472	CcSEcCtD
Amitriptyline—Decreased appetite—Cisplatin—esophageal cancer	0.000498	0.00464	CcSEcCtD
Amitriptyline—Drowsiness—Methotrexate—esophageal cancer	0.000493	0.00459	CcSEcCtD
Amitriptyline—Vision blurred—Capecitabine—esophageal cancer	0.000488	0.00454	CcSEcCtD
Amitriptyline—Tremor—Capecitabine—esophageal cancer	0.000485	0.00452	CcSEcCtD
Amitriptyline—Stomatitis—Methotrexate—esophageal cancer	0.000481	0.00448	CcSEcCtD
Amitriptyline—Ill-defined disorder—Capecitabine—esophageal cancer	0.000481	0.00447	CcSEcCtD
Amitriptyline—HRH1—lymph node—esophageal cancer	0.00048	0.00328	CbGeAlD
Amitriptyline—Feeling abnormal—Cisplatin—esophageal cancer	0.000472	0.0044	CcSEcCtD
Amitriptyline—ADRA2A—lymph node—esophageal cancer	0.000471	0.00322	CbGeAlD
Amitriptyline—Malaise—Capecitabine—esophageal cancer	0.000467	0.00435	CcSEcCtD
Amitriptyline—Syncope—Capecitabine—esophageal cancer	0.000464	0.00432	CcSEcCtD
Amitriptyline—Leukopenia—Capecitabine—esophageal cancer	0.000464	0.00431	CcSEcCtD
Amitriptyline—Agranulocytosis—Methotrexate—esophageal cancer	0.00046	0.00428	CcSEcCtD
Amitriptyline—ABCB1—digestive system—esophageal cancer	0.00046	0.00314	CbGeAlD
Amitriptyline—Palpitations—Capecitabine—esophageal cancer	0.000458	0.00426	CcSEcCtD
Amitriptyline—Loss of consciousness—Capecitabine—esophageal cancer	0.000455	0.00424	CcSEcCtD
Amitriptyline—Body temperature increased—Cisplatin—esophageal cancer	0.000453	0.00422	CcSEcCtD
Amitriptyline—Hypertension—Capecitabine—esophageal cancer	0.000447	0.00416	CcSEcCtD
Amitriptyline—Hepatitis—Methotrexate—esophageal cancer	0.000443	0.00412	CcSEcCtD
Amitriptyline—Anxiety—Capecitabine—esophageal cancer	0.000439	0.00409	CcSEcCtD
Amitriptyline—Discomfort—Capecitabine—esophageal cancer	0.000436	0.00405	CcSEcCtD
Amitriptyline—Dry mouth—Capecitabine—esophageal cancer	0.000431	0.00401	CcSEcCtD
Amitriptyline—Confusional state—Capecitabine—esophageal cancer	0.000426	0.00397	CcSEcCtD
Amitriptyline—Oedema—Capecitabine—esophageal cancer	0.000423	0.00393	CcSEcCtD
Amitriptyline—Shock—Capecitabine—esophageal cancer	0.000416	0.00387	CcSEcCtD
Amitriptyline—Thrombocytopenia—Capecitabine—esophageal cancer	0.000414	0.00385	CcSEcCtD
Amitriptyline—Tinnitus—Methotrexate—esophageal cancer	0.000413	0.00384	CcSEcCtD
Amitriptyline—Tachycardia—Capecitabine—esophageal cancer	0.000413	0.00384	CcSEcCtD
Amitriptyline—Asthenia—Cisplatin—esophageal cancer	0.000411	0.00383	CcSEcCtD
Amitriptyline—Hyperhidrosis—Capecitabine—esophageal cancer	0.000409	0.0038	CcSEcCtD
Amitriptyline—Anorexia—Capecitabine—esophageal cancer	0.000403	0.00375	CcSEcCtD
Amitriptyline—Hypotension—Capecitabine—esophageal cancer	0.000395	0.00368	CcSEcCtD
Amitriptyline—Diarrhoea—Cisplatin—esophageal cancer	0.000392	0.00365	CcSEcCtD
Amitriptyline—Alopecia—Methotrexate—esophageal cancer	0.000391	0.00364	CcSEcCtD
Amitriptyline—ABCB1—lung—esophageal cancer	0.000384	0.00262	CbGeAlD
Amitriptyline—Insomnia—Capecitabine—esophageal cancer	0.000382	0.00356	CcSEcCtD
Amitriptyline—Paraesthesia—Capecitabine—esophageal cancer	0.00038	0.00353	CcSEcCtD
Amitriptyline—Dysgeusia—Methotrexate—esophageal cancer	0.000378	0.00351	CcSEcCtD
Amitriptyline—Dyspepsia—Capecitabine—esophageal cancer	0.000372	0.00346	CcSEcCtD
Amitriptyline—Decreased appetite—Capecitabine—esophageal cancer	0.000367	0.00342	CcSEcCtD
Amitriptyline—Vomiting—Cisplatin—esophageal cancer	0.000365	0.00339	CcSEcCtD
Amitriptyline—Fatigue—Capecitabine—esophageal cancer	0.000364	0.00339	CcSEcCtD
Amitriptyline—Vision blurred—Methotrexate—esophageal cancer	0.000363	0.00338	CcSEcCtD
Amitriptyline—Rash—Cisplatin—esophageal cancer	0.000362	0.00336	CcSEcCtD
Amitriptyline—Constipation—Capecitabine—esophageal cancer	0.000361	0.00336	CcSEcCtD
Amitriptyline—Dermatitis—Cisplatin—esophageal cancer	0.000361	0.00336	CcSEcCtD
Amitriptyline—Ill-defined disorder—Methotrexate—esophageal cancer	0.000358	0.00333	CcSEcCtD
Amitriptyline—Feeling abnormal—Capecitabine—esophageal cancer	0.000348	0.00324	CcSEcCtD
Amitriptyline—Malaise—Methotrexate—esophageal cancer	0.000348	0.00324	CcSEcCtD
Amitriptyline—Leukopenia—Methotrexate—esophageal cancer	0.000345	0.00321	CcSEcCtD
Amitriptyline—Desipramine—CYP2A6—esophageal cancer	0.000341	0.153	CrCbGaD
Amitriptyline—Nausea—Cisplatin—esophageal cancer	0.000341	0.00317	CcSEcCtD
Amitriptyline—Urticaria—Capecitabine—esophageal cancer	0.000336	0.00313	CcSEcCtD
Amitriptyline—Body temperature increased—Capecitabine—esophageal cancer	0.000334	0.00311	CcSEcCtD
Amitriptyline—Convulsion—Methotrexate—esophageal cancer	0.000334	0.00311	CcSEcCtD
Amitriptyline—Discomfort—Methotrexate—esophageal cancer	0.000324	0.00302	CcSEcCtD
Amitriptyline—Nortriptyline—PTGS1—esophageal cancer	0.000318	0.143	CrCbGaD
Amitriptyline—Confusional state—Methotrexate—esophageal cancer	0.000317	0.00295	CcSEcCtD
Amitriptyline—Thrombocytopenia—Methotrexate—esophageal cancer	0.000308	0.00287	CcSEcCtD
Amitriptyline—Hyperhidrosis—Methotrexate—esophageal cancer	0.000304	0.00283	CcSEcCtD
Amitriptyline—Asthenia—Capecitabine—esophageal cancer	0.000303	0.00282	CcSEcCtD
Amitriptyline—Anorexia—Methotrexate—esophageal cancer	0.0003	0.00279	CcSEcCtD
Amitriptyline—Pruritus—Capecitabine—esophageal cancer	0.000299	0.00278	CcSEcCtD
Amitriptyline—Epinastine—ABCB1—esophageal cancer	0.000298	0.134	CrCbGaD
Amitriptyline—Hypotension—Methotrexate—esophageal cancer	0.000294	0.00274	CcSEcCtD
Amitriptyline—Diphenhydramine—PTGS1—esophageal cancer	0.000294	0.132	CrCbGaD
Amitriptyline—Diarrhoea—Capecitabine—esophageal cancer	0.000289	0.00269	CcSEcCtD
Amitriptyline—Insomnia—Methotrexate—esophageal cancer	0.000285	0.00265	CcSEcCtD
Amitriptyline—Paraesthesia—Methotrexate—esophageal cancer	0.000283	0.00263	CcSEcCtD
Amitriptyline—Somnolence—Methotrexate—esophageal cancer	0.00028	0.0026	CcSEcCtD
Amitriptyline—Dizziness—Capecitabine—esophageal cancer	0.000279	0.0026	CcSEcCtD
Amitriptyline—Dyspepsia—Methotrexate—esophageal cancer	0.000277	0.00258	CcSEcCtD
Amitriptyline—Decreased appetite—Methotrexate—esophageal cancer	0.000274	0.00255	CcSEcCtD
Amitriptyline—Fatigue—Methotrexate—esophageal cancer	0.000271	0.00252	CcSEcCtD
Amitriptyline—Vomiting—Capecitabine—esophageal cancer	0.000269	0.0025	CcSEcCtD
Amitriptyline—Rash—Capecitabine—esophageal cancer	0.000266	0.00248	CcSEcCtD
Amitriptyline—Dermatitis—Capecitabine—esophageal cancer	0.000266	0.00248	CcSEcCtD
Amitriptyline—Headache—Capecitabine—esophageal cancer	0.000265	0.00246	CcSEcCtD
Amitriptyline—ABCB1—lymph node—esophageal cancer	0.000263	0.00179	CbGeAlD
Amitriptyline—Feeling abnormal—Methotrexate—esophageal cancer	0.000259	0.00241	CcSEcCtD
Amitriptyline—Nausea—Capecitabine—esophageal cancer	0.000251	0.00234	CcSEcCtD
Amitriptyline—Urticaria—Methotrexate—esophageal cancer	0.00025	0.00233	CcSEcCtD
Amitriptyline—Body temperature increased—Methotrexate—esophageal cancer	0.000249	0.00231	CcSEcCtD
Amitriptyline—Asthenia—Methotrexate—esophageal cancer	0.000226	0.0021	CcSEcCtD
Amitriptyline—Pruritus—Methotrexate—esophageal cancer	0.000223	0.00207	CcSEcCtD
Amitriptyline—Diarrhoea—Methotrexate—esophageal cancer	0.000215	0.002	CcSEcCtD
Amitriptyline—Dizziness—Methotrexate—esophageal cancer	0.000208	0.00194	CcSEcCtD
Amitriptyline—Vomiting—Methotrexate—esophageal cancer	0.0002	0.00186	CcSEcCtD
Amitriptyline—Rash—Methotrexate—esophageal cancer	0.000198	0.00185	CcSEcCtD
Amitriptyline—Dermatitis—Methotrexate—esophageal cancer	0.000198	0.00184	CcSEcCtD
Amitriptyline—Headache—Methotrexate—esophageal cancer	0.000197	0.00183	CcSEcCtD
Amitriptyline—Nausea—Methotrexate—esophageal cancer	0.000187	0.00174	CcSEcCtD
Amitriptyline—Clomipramine—ABCB1—esophageal cancer	0.000158	0.071	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—esophageal cancer	0.000157	0.0707	CrCbGaD
Amitriptyline—Trimipramine—ABCB1—esophageal cancer	0.000145	0.0653	CrCbGaD
Amitriptyline—Promethazine—ABCB1—esophageal cancer	0.00014	0.0629	CrCbGaD
Amitriptyline—Doxepin—ABCB1—esophageal cancer	0.000138	0.0623	CrCbGaD
Amitriptyline—Desipramine—ABCB1—esophageal cancer	0.000127	0.0571	CrCbGaD
Amitriptyline—Imipramine—ABCB1—esophageal cancer	0.000108	0.0484	CrCbGaD
Amitriptyline—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	8.26e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	8.26e-06	1.96e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CCND1—esophageal cancer	8.22e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CCND1—esophageal cancer	8.22e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—EGFR—esophageal cancer	8.22e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—PIK3CA—esophageal cancer	8.22e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	8.22e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—EGFR—esophageal cancer	8.21e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	8.19e-06	1.95e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	8.18e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.18e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PSME2—esophageal cancer	8.17e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PSME1—esophageal cancer	8.17e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	8.15e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—NOS3—esophageal cancer	8.15e-06	1.94e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.13e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PTGS2—esophageal cancer	8.13e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	8.11e-06	1.93e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	8.07e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—ERBB2—esophageal cancer	8.07e-06	1.92e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	8.05e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EP300—esophageal cancer	8.05e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	8.03e-06	1.91e-05	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—PIK3CA—esophageal cancer	7.99e-06	1.9e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CDKN1A—esophageal cancer	7.96e-06	1.89e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CDKN1A—esophageal cancer	7.96e-06	1.89e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MYC—esophageal cancer	7.88e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	7.87e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—PIK3CA—esophageal cancer	7.86e-06	1.87e-05	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—PIK3CA—esophageal cancer	7.84e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—HMOX1—esophageal cancer	7.84e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	7.82e-06	1.86e-05	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	7.79e-06	1.85e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MYC—esophageal cancer	7.77e-06	1.84e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MYC—esophageal cancer	7.76e-06	1.84e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	7.73e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	7.72e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—EGFR—esophageal cancer	7.71e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MYC—esophageal cancer	7.71e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	7.7e-06	1.83e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.69e-06	1.82e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EP300—esophageal cancer	7.64e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—NOS3—esophageal cancer	7.64e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	7.63e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NOS3—esophageal cancer	7.62e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CREBBP—esophageal cancer	7.61e-06	1.81e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—EGFR—esophageal cancer	7.6e-06	1.8e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—EGFR—esophageal cancer	7.59e-06	1.8e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EP300—esophageal cancer	7.57e-06	1.8e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EP300—esophageal cancer	7.57e-06	1.8e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MYC—esophageal cancer	7.55e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—EGFR—esophageal cancer	7.54e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ABCB1—esophageal cancer	7.52e-06	1.79e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NOS3—esophageal cancer	7.49e-06	1.78e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—NOS3—esophageal cancer	7.49e-06	1.78e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—EGFR—esophageal cancer	7.48e-06	1.78e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NOS3—esophageal cancer	7.48e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—NOS3—esophageal cancer	7.47e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PTGS2—esophageal cancer	7.46e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NOS3—esophageal cancer	7.45e-06	1.77e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NOS3—esophageal cancer	7.43e-06	1.76e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—EGFR—esophageal cancer	7.38e-06	1.75e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TP53—esophageal cancer	7.38e-06	1.75e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NOS3—esophageal cancer	7.36e-06	1.75e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	7.34e-06	1.74e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MYC—esophageal cancer	7.33e-06	1.74e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.3e-06	1.73e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—PIK3CA—esophageal cancer	7.25e-06	1.72e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—CREBBP—esophageal cancer	7.23e-06	1.72e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—CREBBP—esophageal cancer	7.19e-06	1.71e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CCND1—esophageal cancer	7.17e-06	1.7e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—EGFR—esophageal cancer	7.17e-06	1.7e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—PIK3CA—esophageal cancer	7.15e-06	1.7e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—PIK3CA—esophageal cancer	7.14e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CCND1—esophageal cancer	7.13e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—ERBB2—esophageal cancer	7.12e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—PIK3CA—esophageal cancer	7.12e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	7.1e-06	1.69e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	7.08e-06	1.68e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.05e-06	1.67e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MYC—esophageal cancer	7.02e-06	1.67e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—ERBB2—esophageal cancer	7.01e-06	1.66e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	7.01e-06	1.66e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—ERBB2—esophageal cancer	6.99e-06	1.66e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PTGS2—esophageal cancer	6.99e-06	1.66e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	6.99e-06	1.66e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	6.97e-06	1.65e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	6.95e-06	1.65e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	6.93e-06	1.65e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CDKN1A—esophageal cancer	6.9e-06	1.64e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	6.88e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EGFR—esophageal cancer	6.86e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	6.86e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PTGS2—esophageal cancer	6.85e-06	1.63e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PTGS2—esophageal cancer	6.83e-06	1.62e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	6.83e-06	1.62e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NOS3—esophageal cancer	6.82e-06	1.62e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—EP300—esophageal cancer	6.76e-06	1.6e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	6.69e-06	1.59e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MYC—esophageal cancer	6.66e-06	1.58e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.65e-06	1.58e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.63e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	6.6e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EP300—esophageal cancer	6.6e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MYC—esophageal cancer	6.6e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MYC—esophageal cancer	6.6e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—PIK3CA—esophageal cancer	6.59e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—PIK3CA—esophageal cancer	6.59e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EP300—esophageal cancer	6.56e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—PIK3CA—esophageal cancer	6.54e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EGFR—esophageal cancer	6.51e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—PIK3CA—esophageal cancer	6.49e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TP53—esophageal cancer	6.47e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—NOS3—esophageal cancer	6.47e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EGFR—esophageal cancer	6.45e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EGFR—esophageal cancer	6.45e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CREBBP—esophageal cancer	6.45e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—NOS3—esophageal cancer	6.43e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	6.41e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TP53—esophageal cancer	6.38e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—ERBB2—esophageal cancer	6.38e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TP53—esophageal cancer	6.37e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TP53—esophageal cancer	6.33e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CREBBP—esophageal cancer	6.3e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCND1—esophageal cancer	6.29e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EP300—esophageal cancer	6.28e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—PIK3CA—esophageal cancer	6.22e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—EP300—esophageal cancer	6.2e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TP53—esophageal cancer	6.2e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCND1—esophageal cancer	6.19e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCND1—esophageal cancer	6.18e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCND1—esophageal cancer	6.16e-06	1.46e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCND1—esophageal cancer	6.14e-06	1.46e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CDKN1A—esophageal cancer	6.09e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCND1—esophageal cancer	6.08e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	6.06e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.05e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TP53—esophageal cancer	6.02e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CDKN1A—esophageal cancer	5.99e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CDKN1A—esophageal cancer	5.98e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	5.96e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	5.96e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	5.94e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CREBBP—esophageal cancer	5.93e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTGS2—esophageal cancer	5.92e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTGS2—esophageal cancer	5.88e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.88e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	5.88e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	5.87e-06	1.39e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—EP300—esophageal cancer	5.81e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.8e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EP300—esophageal cancer	5.79e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—NOS3—esophageal cancer	5.78e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—esophageal cancer	5.76e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—esophageal cancer	5.75e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—esophageal cancer	5.72e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EP300—esophageal cancer	5.7e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—EP300—esophageal cancer	5.69e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EP300—esophageal cancer	5.69e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.69e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—EP300—esophageal cancer	5.68e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EP300—esophageal cancer	5.67e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	5.65e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EP300—esophageal cancer	5.65e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—NOS3—esophageal cancer	5.64e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—esophageal cancer	5.63e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—esophageal cancer	5.62e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—esophageal cancer	5.6e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—esophageal cancer	5.6e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EP300—esophageal cancer	5.6e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—esophageal cancer	5.59e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EP300—esophageal cancer	5.58e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—esophageal cancer	5.48e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—esophageal cancer	5.47e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1A—esophageal cancer	5.45e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—esophageal cancer	5.42e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—esophageal cancer	5.42e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	5.36e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—NOS3—esophageal cancer	5.31e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.28e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—NOS3—esophageal cancer	5.27e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EP300—esophageal cancer	5.19e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—esophageal cancer	5.16e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—esophageal cancer	5.05e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CREBBP—esophageal cancer	5.03e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—esophageal cancer	5e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—esophageal cancer	4.97e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—esophageal cancer	4.96e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—esophageal cancer	4.94e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—esophageal cancer	4.94e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—esophageal cancer	4.92e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—EP300—esophageal cancer	4.92e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—EP300—esophageal cancer	4.89e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	4.88e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—esophageal cancer	4.88e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—esophageal cancer	4.86e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.86e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—esophageal cancer	4.86e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—esophageal cancer	4.86e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—esophageal cancer	4.85e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—esophageal cancer	4.83e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.82e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—esophageal cancer	4.82e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—esophageal cancer	4.77e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	4.76e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—esophageal cancer	4.72e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—esophageal cancer	4.7e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	4.65e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—esophageal cancer	4.59e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—esophageal cancer	4.52e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—NOS3—esophageal cancer	4.5e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—esophageal cancer	4.5e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—esophageal cancer	4.42e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—EP300—esophageal cancer	4.39e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—esophageal cancer	4.3e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—EP300—esophageal cancer	4.29e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—esophageal cancer	4.29e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—esophageal cancer	4.22e-06	1e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—esophageal cancer	4.21e-06	1e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—esophageal cancer	4.21e-06	9.99e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—esophageal cancer	4.2e-06	9.98e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	4.19e-06	9.96e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	4.18e-06	9.92e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—esophageal cancer	4.15e-06	9.84e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	4.14e-06	9.83e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	4.13e-06	9.8e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—esophageal cancer	4.12e-06	9.77e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—esophageal cancer	4.08e-06	9.68e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—esophageal cancer	4.07e-06	9.66e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—esophageal cancer	4.06e-06	9.63e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—esophageal cancer	4.04e-06	9.6e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—EP300—esophageal cancer	4.04e-06	9.59e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—EP300—esophageal cancer	4.01e-06	9.51e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—esophageal cancer	4e-06	9.51e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—esophageal cancer	3.99e-06	9.48e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.88e-06	9.21e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—esophageal cancer	3.84e-06	9.11e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—esophageal cancer	3.71e-06	8.81e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—esophageal cancer	3.64e-06	8.64e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—esophageal cancer	3.62e-06	8.59e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NOS3—esophageal cancer	3.47e-06	8.25e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—EP300—esophageal cancer	3.42e-06	8.13e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.25e-06	7.72e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.18e-06	7.54e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.17e-06	7.53e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.99e-06	7.1e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.96e-06	7.04e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—EP300—esophageal cancer	2.64e-06	6.27e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.53e-06	6.01e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.95e-06	4.64e-06	CbGpPWpGaD
